<DOC>
	<DOCNO>NCT02088177</DOCNO>
	<brief_summary>This 8 week , outpatient research study test use long-acting naltrexone ( Vivitrol ) treatment marijuana dependence . Vivitrol medication effective treat dependence opiate opioids , treat dependence alcohol . It FDA approve disorder . It long-acting medication contains enough medicine injection last one month . One way work block effect opiate , include opiate release body response drug alcohol . In study , interested test effect Vivitrol people marijuana dependence . Individuals participate study receive two Vivitrol injection , give four week apart , ( week 1 week 5 ) . The injection give muscle buttock one side . Participants attend clinic visit two time week 8-week study medical management drug use monitor physical psychological health .</brief_summary>
	<brief_title>Study Long-Acting Injectable Naltrexone Treat Cannabis Dependence</brief_title>
	<detailed_description>This 8 week , outpatient , open-label clinical trial long-acting injectable naltrexone treatment cannabis dependence . The purpose study evaluate marijuana use patterns tolerability long-acting naltrexone 7 treatment-seeking , cannabis-dependent outpatient ; also assess feasibility conduct large trial medication . Cannabis dependent patient twice weekly clinic visit receive injection Vivitrol four week apart , Week 1 Week 5 . The psychosocial intervention study Medical Management , design facilitate adherence study medication monitoring procedure , well support participant achieve marijuana use goal . Participants self-report cannabis use , provide urine toxicology quantitative assessment THC ( Tetrahydrocannabinol , active ingredient marijuana ) , provide serum sample safety monitoring , answer questionnaire report physical psychological health weekly .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Between age 18 60 year Meets DSMIV ( Diagnostic Statistical Manual Mental Disorders , edition IVTR ) criteria cannabis dependence Seeking treatment cannabis dependence Reports use cannabis average 5 day per week past 28 day Capable give informed consent comply study procedure Lifetime history DSMIV diagnosis schizophrenia , schizoaffective disorder , bipolar disorder Currently meeting DSMIV criterion psychiatric disorder , accord investigator 's judgment , may require pharmacological nonpharmacological intervention course study Receiving opioid analgesic medication Known history allergy , intolerance , hypersensitivity naltrexone Pregnancy , lactation , failure use adequate contraceptive method female participant actively engage sexual activity men Unstable medical condition , poorly control hypertension liver disease , might make participation hazardous Chronic pain condition Liver dysfunction indicate elevate liver transaminases great 2 time upper limit normal Current DSMIV diagnosis substance dependence nicotine cannabis dependence Legally mandate participate substance use disorder treatment program Risk suicide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cannabis</keyword>
	<keyword>Cannabis Dependence</keyword>
	<keyword>Cannabis Use Disorder</keyword>
	<keyword>Marijuana</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>Long Acting Injectable Naltrexone</keyword>
	<keyword>Treatment</keyword>
</DOC>